0001209191-20-055716.txt : 20201023
0001209191-20-055716.hdr.sgml : 20201023
20201023172251
ACCESSION NUMBER: 0001209191-20-055716
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201021
FILED AS OF DATE: 20201023
DATE AS OF CHANGE: 20201023
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SANDS ARTHUR T
CENTRAL INDEX KEY: 0001134106
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39398
FILM NUMBER: 201258558
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nurix Therapeutics, Inc.
CENTRAL INDEX KEY: 0001549595
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270838048
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1130
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 205
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: (415) 660-5320
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 205
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
FORMER COMPANY:
FORMER CONFORMED NAME: Nurix, Inc.
DATE OF NAME CHANGE: 20120509
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-21
0
0001549595
Nurix Therapeutics, Inc.
NRIX
0001134106
SANDS ARTHUR T
C/O NURIX THERAPEUTICS, INC.
1700 OWENS STREET, SUITE 205
SAN FRANCISCO
CA
94158
1
1
0
0
President, CEO
Stock Option (right to buy)
26.91
2020-10-21
4
A
0
804170
0.00
A
2030-10-20
Common Stock
804170
804170
D
The stock option vests as to 1/48 of the total shares monthly beginning August 23, 2020 until the option is fully vested on July 23, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Christine Ring, as Attorney-in-Fact for Arthur T. Sands
2020-10-23